NDA submitted to FDA and MAA validated by EMA in December 2023 Submissions are based on positive results from Phase 3 registrational ACTION-Galactosemia Kids study demonstrating consistent long-term.
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 3,400,000 shares, an increase of 71.7% from the November 15th total of 1,980,000 shares. Based on an average daily volume of 1,070,000 shares, the short-interest ratio is currently 3.2 […]
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) CEO Shoshana Shendelman sold 115,632 shares of the firm’s stock in a transaction that occurred on Wednesday, September 27th. The stock was sold at an average price of $2.70, for a total value of $312,206.40. Following the completion of the sale, the chief executive officer now directly […]